MKI67 and neoplasm: Median Ki-67 expression was 17.5% (range 0 to 50%, interquartile range 5–20%), which is significantly dependent on the WHO grade of the operated tumor (median Ki-67 expression in WHO II tumors 3.5%, WHO III tumors 15%, WHO IV tumors 20%, p = 0.006).